Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: A national survey

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Mallet, Pauline ^a,b   Mourdi, Nadjette ^c   Dubus, Jean Christophe ^d   Bavoux, Françoise ^b   Boyer Gervoise, Marie José ^e   Jean Pastor, Marie Josèphe ^e   Chalumeau, Martin ^a,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Institut Cochin   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d TIMONE HOSPITAL   (France)

^e Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBOCISTEINE; CORTICOSTEROID; EXPECTORANT AGENT;

ARTICLE; ASTHMA; BRONCHIOLITIS; BRONCHITIS; BRONCHORRHEA; BRONCHOSPASM; CHILD; CHILD DEATH; CHILD HEALTH CARE; CHILD HOSPITALIZATION; COUGHING; DATA BASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG RECALL; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; FRANCE; HEALTH SURVEY; HUMAN; INFANT; ITALY; LUNG EDEMA; MAJOR CLINICAL STUDY; MUCUS SECRETION; NEWBORN; PARADOXICAL DRUG REACTION; PARENT; PHARMACIST; PHYSICIAN; PNEUMONIA; PRACTICE GUIDELINE; PRESCHOOL CHILD; RECOMMENDED DRUG DOSE; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT DURATION; FEMALE; MALE;

ACETYLCYSTEINE; CARBOCYSTEINE; CHILD; CHILD, PRESCHOOL; EXPECTORANTS; FEMALE; FRANCE; HEALTH SURVEYS; HUMANS; INFANT; MALE; RESPIRATORY TRACT DISEASES;

EID: 79960798404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022792     Document Type: Article

References (30)

1. Medici TC, Radielovic P, (1979) Effects of drugs on mucus glycoproteins and water in bronchial secretion. J Int Med Res 7: 434-42.
2. Duijvestijn YC, Gerritsen J, Brand PL, (1997) Acetylcysteine in children with lung disorders prescribed by one-third of family physicians: no support in the literature. Ned Tijdschr Geneeskd 141: 826-30.
3. Cazzato T, Pandolfini C, Campi R, Bonati M, (2001) Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 57: 611-6.
4. Sanz EJ, Boada JN, (1988) Drug utilization by children in Tenerife Island. Eur J Clin Pharmacol 34: 495-9.
5. Chalumeau M, Treluyer JM, Salanave B, Assathiany R, Chéron G, et al. (2000) Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 83: 502-5.
6. Collet JP, Bossard N, Floret D, Gillet J, Honegger D, et al. (1991) Drug prescription in young children: results of a survey in France. Epicreche Research Group. Eur J Clin Pharmacol 41: 489-91.
7. David M, Luc-Vanuxem C, Loundou A, Bosdure E, Auquier P, et al. (2010) Assessment of the French consensus conference for acute viral bronchiolitis on outpatient management: progress between 2003 and 2008. Arch Pediatr 17: 125-31.
8. Bücheler R, Schwab M, Mörike K, Kalchthaler B, Mohr H, et al. (2002) Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 324: 1311-2.
9. Bricks LF, Leone C, (1996) Use of medicines by children attending nursery schools. Rev Saude Publica 30: 527-35.
10. Blog PharHamster. L'Afssaps interdit les mucolytiques chez les moins de 2 ans. Available: http://pharamster.over-blog.com/article-l-afssaps-interdit-les-mucolytiques-chez-les-moins-de-2-ans-51932598.html. Accessed 2010 Oct 25.
11. Public Health Advisory (2008) FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age. Available: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051137.html. Accessed 2010 Oct 25.
12. Chalumeau M, Cheron G, Assathiany R, Moulin F, Bavoux F, et al. (2002) Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? Arch Pediatr 9: 1128-36.
13. Duijvestijn YC, Mourdi N, Smucny J, Pons G, Chalumeau M, (2009) Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev CD003124.
14. Afssaps (2009) Comission nationale de pharmacovigilance du 24 mars 2009. Available: http://www.afssaps.fr/var/afssaps_site/storage/original/application/7705f2db6f54e980bc0695c6ca8358a3.pdf. Accessed 2010 Oct 25.
15. Afssaps (2010) Médicaments mucolytiques, mucofluidifiants et Hélicidine®: contre-indication chez l'enfant de moins de deux ans- Communiqué. Available: http://www.afssaps.fr/Infos-de-securite/Communiques-Points-presse/Medicaments-mucolytiques-mucofluidifiants-et-Helicidine-R-contre-indication-chez-l-enfant-de-moins-de-deux-ans-Communique. Accessed 2010 Oct 25.
16. Mourdi N, Dubus JC, Bavoux F, Boyer-Gervoise M, Jean-Pastor MJ, et al. (2010) Mucolytic drugs: towards a contraindication in infants. Arch Pediatr 17: 735-6.
17. Commitee for Medical Products for Human Use (2005) Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. Available: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003764.pdf. Accessed 2010 Oct 25.
18. Kelly W, Arellano F, Barnes J, Bergman U, Edwards R, et al. (2007) Guidelines for submitting adverse event reports for publication. Pharmacoepidemiology and Drug Safety 16: 581-587.
19. Journal Officiel de la République Française (2005) Arreté du 28 avril 2005 relatif aux bonnes pratiques de pharmacovigilance. Available: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000812853 &dateTexte =. Accessed 2010 Oct 25.
20. Afssaps. Déclaration d'effet indésirable suceptible d'être dû à un médicament ou produit. Available: http://www.sante.gouv.fr/cerfa/efindes/abvitot.pdf. Accessed 2010 Oct 25.
21. Dictionnaire Vidal 2010 (2009) Paris Editions du Vidal.
22. Wohl M, (1998) Developmental physiology of the respiratory system. pp. 19-27 Kendig's Disorders of the Respiratory Tract in Children.
23. Harris RL, Riley HD Jr, (1967) Reactions to aerosol medication in infants and children. JAMA 201: 953-5.
24. Jean R, (1982) Efficacy on expectoration of acetylcysteine nebulization in paediatric patients Paris Laboratoires Zambon.
25. Anonymous (2000) Acetylcysteine. pp. 472-4 American Hospital Formulary system Drug Information.
26. Anonymous (2000) Acetylcysteine. pp. 677-9 Drug Facts and Comparisons.
27. Micromedex (2010) Acetylcysteine. In Drugdex. Available: http://www.thomsonhc.com/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/6D4ED8/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/3F50A8/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.DisplayDrugdexDocument?docId=004590&contentSetId=100. Accessed 2010 Nov 16.
28. WHO (2007) WHO Child Growth Standards. Weight-for-age. Available: http://www.who.int/childgrowth/standards/weight_for_age/en/index. Accessed 2010 Oct 25.
29. Anonymous (1987) Etude de la tolérance clinique du sirop carbocysteine chez l'enfant Aubervilliers, France Laboratoires Alpharma.
30. Begaud B, Martin K, Haramburu F, Moore N, (2002) Rates of spontaneous reporting of adverse drug reactions in France. JAMA 288: 1588.